Wells Fargo Keeps Their Buy Rating on Veeva Systems (VEEV)
Wells Fargo analyst Stan Berenshteyn maintained a Buy rating on Veeva Systems today and set a price target of $317.00.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Berenshteyn covers the Healthcare sector, focusing on stocks such as Omnicell, Healthequity, and Omada Health, Inc.. According to TipRanks, Berenshteyn has an average return of -10.9% and a 39.68% success rate on recommended stocks.
In addition to Wells Fargo, Veeva Systems also received a Buy from William Blair’s Dylan Becker in a report issued yesterday. However, on March 5, BMO Capital maintained a Hold rating on Veeva Systems (NYSE: VEEV).
Based on Veeva Systems’ latest earnings release for the quarter ending January 31, the company reported a quarterly revenue of $835.95 million and a net profit of $244.2 million. In comparison, last year the company earned a revenue of $720.89 million and had a net profit of $195.63 million
Read More on VEEV:
Disclaimer & DisclosureReport an Issue
- Veeva acquires brand engagement platform Ostro for $100M up-front
- Veeva price target lowered to $291 from $319 at Citi
- Veeva price target lowered to $219 from $319 at Citi
- Veeva Systems Earnings Call Highlights Growth And Margins
- Veeva Systems: Broad Biopharma Demand, Emerging AI Traction, and Durable Moat Support Long‑Term Growth and Justify Buy Rating
